Sachiko Sato is Professor of Faculty of Medicine at the Université Laval. She received her B. Pharm. from Chiba University in Japan and her M. Pharm. and Ph. D at the University of Tokyo, Japan (1994, Pharmaceutical sciences (glycobiology)). During the period of Ph. D. training, she spent 3 years in the laboratory of Dr. R. Hughes at MRC: National Institution for Medical Research, London, UK. She received post-doc training in the laboratory of Dr. Ron. R. Kopito at Stanford University (Cell Biology), US. In 1999, she was recruited as assistant professor of the Faculty of Medicine, Université Laval and principal investigator in Research Centre for Infectious Diseases at the university hospital centre (CHUQ), where she has a laboratory of glycobiology and bioimaging. She is also director of the Bioimaging platform in this centre since 2005. Her research is focused on the glycobiology of host-pathogen interaction. She was the first to propose that intracellular host glycan-binding proteins function as “danger signals” or a danger-associated molecular patterns (DAMPs) to initiate innate immune response upon pathogenic infections and is invited to write several reviews and give lectures. Recognitions include a Human Frontier Science Program Long-term post-doctoral fellowship, a MRC post-doctoral fellowship, scholarship awards (junior and senior levels) from the Fonds de la Recherche en Santé du Queébec (FRSQ).
- NEWS & EVENTS
- CORE SERVICES